Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity
New England Journal of Medicine · 14.08.2025 · 393 (7) · 635-647
DOI: 10.1056/nejmoa2502081 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift New England Journal of Medicine, erschienen am 14.08.2025. Verfasst von W Timothy Garvey und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition Sciences, University of Alabama at Birmingham, Birmingham. Hauptthemen laut MEDLINE: Anti-Obesity Agents, Obesity, Overweight, Weight Loss. Die Arbeit wurde bisher 252-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Novo Nordisk A/S.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Nutrition Sciences, University of Alabama at Birmingham, Birmingham.
- Helmholtz Institute for Metabolic, Obesity, and Vascular Research (HI-MAG) of the Helmholtz Zentrum München at the University of Leipzig, Leipzig, Germany.
- Medical Department III - Clinical Obesity Research, University of Leipzig Medical Center, Leipzig, Germany.
- Novo Nordisk, Søborg, Denmark.
- Diabetes Research Centre, University of Leicester, Leicester, United Kingdom.
- NIHR Leicester Biomedical Research Centre, Leicester, United Kingdom.
Förderung
- Novo Nordisk A/S
Zitieren
APA
Garvey, W. T., Blüher, M., Osorto Contreras, C. K., Davies, M. J., Winning Lehmann, E., Pietiläinen, K. H., Rubino, D., Sbraccia, P., Wadden, T., Zeuthen, N., Wilding, J. P. H., & REDEFINE 1 Study Group (2025). Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 393(7), 635-647. https://doi.org/10.1056/nejmoa2502081
Vancouver
Garvey WT, Blüher M, Osorto Contreras CK, Davies MJ, Winning Lehmann E, Pietiläinen KH, et al. Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. 2025;393(7):635-647. doi:10.1056/nejmoa2502081
BibTeX
@article{Garvey2025,
author = {Garvey, W Timothy and Blüher, Matthias and Osorto Contreras, Cynthia Karenina and Davies, Melanie J and Winning Lehmann, Eva and Pietiläinen, Kirsi H and Rubino, Domenica and Sbraccia, Paolo and Wadden, Thomas and Zeuthen, Niels and Wilding, John P H and REDEFINE 1 Study Group, REDEFINE 1 Study Group},
title = {Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity},
journal = {New England Journal of Medicine},
year = {2025},
volume = {393},
number = {7},
pages = {635--647},
doi = {10.1056/nejmoa2502081}
}
EUVIMED